Form 4 for HCA HCA Healthcare
Accepted 2021-07-23 00:00:00 ET · period of report 2021-07-21 · accession 0001209191-21-048073 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-23 | 2021-07-21 | HCA | Paslick P. Martin | SVP, CIO | M - OptEx | $69.58 | +17.1K | 30.0K | +133% | +$1.19M |
| D | 2021-07-23 | 2021-07-21 | HCA | Paslick P. Martin | SVP, CIO | F - Tax | $249.25 | -9,614 | 20.3K | -32% | -$2.40M |
| D | 2021-07-23 | 2021-07-21 | HCA | Paslick P. Martin | SVP, CIO | M - OptEx | $0.00 | -17.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-21 | M | A | 17,080 | $69.58 | 29,958 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-21 | F | D | 9,614 | $249.25 | 20,344 | D | — | — | |
| 3 | Derivative | Stock Appreciation Right | 2021-07-21 | M | D | 17,080 | $0.00 | 0 | D | $69.58 · — to 2026-01-29 | 17,080 Common Stock | (F1) The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. |